[1]Signorini V, Elefante E, Zucchi D, et al. One year in review 2020: systemic lupus erythematosus[J]. Clin Exp Rheumatol, 2020,38(4):592-601.
[2]Ma K, Du W, Wang X, et al. Multiple functions of B cells in the pathogenesis of systemic lupus erythematosus[J]. Int J Mol Sci, 2019,20(23):6021.
[3]Chong BF, Mohan C. Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus[J]. Expert Opin Ther Targets, 2009,13(10):1147-1153.
[4]Hanaoka H, Okazaki Y, Hashiguchi A, et al. Overexpression of CXCR4 on circulating B cells in patients with active systemic lupus erythematosus[J]. Clin Exp Rheumatol, 2015,33(6):863-870.
[5]Li H, Tian Y, Xie L, et al. Mesenchymal stem cells in allergic diseases: Current status[J]. Allergol Int, 2020,69(1):35-45.
[6]Cheng RJ, Xiong AJ, Li YH, et al. Mesenchymal stem cells: allogeneic MSC may be immunosuppressive but autologous MSC are dysfunctional in lupus patients[J].Front Cell Dev Biol, 2019,7:285.
[7]Wang M, Yuan Q, Xie L. Mesenchymal stem cellbased immunomodulation: properties and clinical application[J].Stem Cells Int, 2018,2018:1-12.
[8]Yuan L, Xiao ZT, Huang XZ, et al. Human embryonic mesenchymal stem cells alleviate pathologic changes of MRL/Lpr mice by regulating Th7 cell differentiation[J]. Ren Fail, 2016,38(9):1432-1440.
[9]白静.免疫球蛋白与补体C3、C4联合检测对系统性红斑狼疮的诊断价值[J].医疗装备, 2020,33(4):32-33.
[10]Flynn RJ. CD95 and the MRLlpr mouse model[J]. Methods Mol Biol, 2017,1557:219-228.
[11]Thong B, Olsen NJ. Systemic lupus erythematosus diagnosis and management[J]. Rheumatology(Oxford), 2017, 56(suppl_1):i3-i13.
[12]束庆,范晴晴,刘蕴星,等.间充质干细胞移植在治疗自身免疫性疾病中的应用进展[J].药学进展, 2019,43(4):276-281.
[13]Ji J, Wu Y, Meng Y, et al. JAKSTAT signaling mediates the senescence of bone marrowmesenchymal stem cells from systemic lupus erythematosus patients[J]. Acta Biochim Biophys Sin (Shanghai), 2017,49(3):1-8.
[14]de la Varga Martínez R,RodríguezBayona B,Aez GA, et al. Clinical relevance of circulating antiENA and antidsDNA secreting cells from SLE patients and their dependence on STAT3 activation[J]. Eur J Immunol, 2017,47(7):1211-1219.
[15]Malkiel S, Barlev AN, AtishaFregoso Y, et al. Plasma cell differentiation pathways in systemic lupus erythematosus[J].Front Immunol, 2018,9:427-448.
[16]Ma K, Li J, Wang X, et al.TLR4+CXCR4+ plasma cells drive nephritis development in systemic lupus erythematosus[J].Ann Rheum Dis, 2018,77(10):1498-1506.
[17]Adriano T, Laleh K, Caroline V, et al. Longlived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors[J].Arthritis Res Ther, 2015,17(1):1-12.
[18]Ellyard JI, Avery DT, Mackay CR, et al. Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL6 and CD54[J].Eur J Immunol, 2005,35(3):699-708.
[19]Wang W, RangelMoreno J, Owen T, et al. Longterm B cell depletion in murine lupus eliminates autoantibodysecreting cells and is associated with alterations in the kidney plasma cell niche[J].J Immunol, 2014,192(7):3011-3020.
|